Reyon Pharma controlling stake slips to 53.84% after related-party off-market sale

Bitget2026/09/28 08:10

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Reyon Pharmaceutical’s controlling shareholder group cut its stake in Ilyon Pharmaceutical to 10,006,691 shares from 10,105,310.
Ownership fell to 53.84% from 54.37% as related party Yoo Jeong-min sold 98,619 shares off-market on Sept. 18, 2026.
The sale price was 10,140 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reyon Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260928000328), on September 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Reyon Pharma controlling stake slips to 53.84% after related-party off-market sale

You may also like

Crypto prices